|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/435 | |
| A61K 38/00 |
| (11) | Patento numeris | 2393831 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10703194.0 |
| Europos patento paraiškos padavimo data | 2010-02-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-12-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-05-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2010/000213 |
| Data | 2010-02-04 |
| (87) | Numeris | WO 2010/100396 |
| Data | 2010-09-10 |
| (30) | Numeris | Data | Šalis |
| PCT/GB2009/0003 | 2009-02-05 | WO | |
| 0906779 | 2009-04-20 | GB |
| (72) |
NUNN, Miles, A., GB
LEA, Susan, M., GB
ROVERSI, Pietro, C., GB
|
| (73) |
Volution Immuno Pharmaceuticals SA,
Place Des Eaux Vives 6,, 3461-1211 Geneve 3,
CH
|
| (54) | MODIFIED OMCI AS A COMPLEMENT INHIBITOR |
| MODIFIED OMCI AS A COMPLEMENT INHIBITOR |